Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial B Bonanni, M Puntoni, M Cazzaniga, G Pruneri, D Serrano, ... Journal of clinical oncology 30 (21), 2593-2600, 2012 | 306 | 2012 |
Randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia A DeCensi, M Puntoni, A Guerrieri-Gonzaga, S Caviglia, F Avino, ... Journal of Clinical Oncology 37 (19), 1629-1637, 2019 | 174 | 2019 |
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast G Pruneri, M Lazzeroni, V Bagnardi, GB Tiburzio, N Rotmensz, A DeCensi, ... Annals of Oncology 28 (2), 321-328, 2017 | 103 | 2017 |
Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug M Lazzeroni, D Serrano, BK Dunn, BM Heckman-Stoddard, O Lee, ... Breast Cancer Research 14, 1-11, 2012 | 100 | 2012 |
The effect of metformin on apoptosis in a breast cancer presurgical trial M Cazzaniga, A DeCensi, G Pruneri, M Puntoni, L Bottiglieri, C Varricchio, ... British journal of cancer 109 (11), 2792-2797, 2013 | 95 | 2013 |
Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial D Serrano, M Lazzeroni, CF Zambon, D Macis, P Maisonneuve, ... The pharmacogenomics journal 11 (2), 100-107, 2011 | 88 | 2011 |
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial A DeCensi, M Puntoni, S Gandini, A Guerrieri-Gonzaga, HA Johansson, ... Breast cancer research and treatment 148, 81-90, 2014 | 87 | 2014 |
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users A Decensi, S Gandini, D Serrano, M Cazzaniga, M Pizzamiglio, F Maffini, ... Journal of clinical oncology 25 (27), 4201-4209, 2007 | 83 | 2007 |
Prognostic effect of circulating adiponectin in a randomized 2× 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer D Macis, S Gandini, A Guerrieri-Gonzaga, H Johansson, P Magni, ... Journal of clinical oncology 30 (2), 151, 2012 | 73 | 2012 |
Randomized phase ii trial of inhaled budesonide versus placebo in high-risk individuals with CT screen–detected lung nodules G Veronesi, E Szabo, A DeCensi, A Guerrieri-Gonzaga, M Bellomi, ... Cancer Prevention Research 4 (1), 34-42, 2011 | 67 | 2011 |
Risk of subsequentin situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinomain situ G Curigliano, D Disalvatore, A Esposito, G Pruneri, M Lazzeroni, ... Annals of Oncology 26 (4), 682-687, 2015 | 66 | 2015 |
A presurgical study of lecithin formulation of green tea extract in women with early breast cancer M Lazzeroni, A Guerrieri-Gonzaga, S Gandini, H Johansson, D Serrano, ... Cancer Prevention Research 10 (6), 363-370, 2017 | 65 | 2017 |
Vitamin D supplementation and cancer: review of randomized controlled trials M Lazzeroni, D Serrano, S Pilz, S Gandini Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 59 | 2013 |
Lapatinib activity in premalignant lesions and HER-2–positive cancer of the breast in a randomized, placebo-controlled presurgical trial A DeCensi, M Puntoni, G Pruneri, A Guerrieri-Gonzaga, M Lazzeroni, ... Cancer prevention research 4 (8), 1181-1189, 2011 | 59 | 2011 |
Synthetic retinoid fenretinide in breast cancer chemoprevention B Bonanni, M Lazzeroni, U Veronesi Expert review of anticancer therapy 7 (4), 423-432, 2007 | 57 | 2007 |
The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis S Gandini, M Lazzeroni, FA Peccatori, B Bendinelli, C Saieva, D Palli, ... Critical reviews in oncology/hematology 134, 72-81, 2019 | 53 | 2019 |
A presurgical study of oral silybin-phosphatidylcholine in patients with early breast cancer M Lazzeroni, A Guerrieri-Gonzaga, S Gandini, H Johansson, D Serrano, ... Cancer Prevention Research 9 (1), 89-95, 2016 | 48 | 2016 |
A randomized trial of robotic mastectomy versus open surgery in women with breast cancer or BrCA mutation A Toesca, C Sangalli, P Maisonneuve, G Massari, A Girardi, JL Baker, ... Annals of surgery 276 (1), 11-19, 2022 | 45 | 2022 |
Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype M Lazzeroni, A Guerrieri-Gonzaga, E Botteri, MC Leonardi, N Rotmensz, ... British journal of cancer 108 (8), 1593-1601, 2013 | 44 | 2013 |
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials S Gandini, A Guerrieri-Gonzaga, G Pruneri, D Serrano, M Cazzaniga, ... Annals of oncology 25 (3), 618-623, 2014 | 38 | 2014 |